MetaCap

Akebia Therapeutics Inc. (AKBA)

NASDAQ: AKBAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.8734-0.0051 (-0.58%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

AKBA stock chart

Technical analysis

Key statistics

All statistics
Market cap
$242.02M
EPS (TTM)
-$0.12
52-week range
0.814 – 3.20
Day range
0.8633 – 0.8871
Volume / Avg
9.16M / 6.09M
Beta
—

52-week range

$0.814$3.20

AKBA stock today

Shares of Akebia Therapeutics (AKBA) finished lower on Oct 7 at $0.8734, a drop of 0.58% or $0.0051 per share, versus the S&P 500's 0.22% decline. Shares are 72.7% below their 52-week high of $3.20, set on Oct 28, 2025 and 7.3% above the 52-week low of $0.814, near the bottom of the past year's range. AKBA is down 45.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 70.4%.

Akebia Therapeutics has posted a net loss over the last twelve months (EPS of -$0.12), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Akebia Therapeutics

Company profile
Industry
Biotechnology: Pharmaceutical Preparations
Headquarters
Cambridge, MA
IPO year
2014

Akebia Therapeutics peers

Health Care sector
AKBA peer companies
CompanyPrice% ChgMarket capCompare
VCREVicore Pharma Holding AB ADR8.66-2.74%$243.90Mvs AKBA
LFCRLifecore Biomedical Inc.6.44-0.15%$244.11Mvs AKBA
CAMPCAMP4 Therapeutics Corporation3.84-3.03%$240.97Mvs AKBA
PYXSPyxis Oncology Inc.2.01-0.49%$240.11Mvs AKBA
VOGXVogenx Inc16.16-1.40%$240.06Mvs AKBA
QTTBQ32 Bio Inc.7.99-1.48%$237.86Mvs AKBA
IMRXImmuneering Corporation Class A3.86+0.78%$249.73Mvs AKBA
ZNTLZentalis Pharmaceuticals Inc.2.55-4.49%$250.21Mvs AKBA

Indexes, lists and sector

Akebia Therapeutics stock FAQ

What is Akebia Therapeutics's stock price today?

AKBA last traded at $0.8734 as of Oct 7, 4:00 PM EDT, down 0.58% on the day. Prices are delayed at least 15 minutes.

What is the AKBA 52-week high?

The 52-week high for AKBA is $3.20 and the 52-week low is $0.814. The stock is currently 72.7% below its high.

Compare AKBA